Search research articles
Contact Us
Filters
Showing results (21-30 of 70) with videos related to
Page
of 7
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
February 10, 2023
N,N-dimethyltryptamine affects electroencephalography response in a concentration-dependent manner-A pharmacokinetic/pharmacodynamic analysis
Emma Eckernäs, Christopher Timmermann, Robin Carhart-Harris, et al.
European Journal of Clinical Pharmacology
|
September 25, 2014
Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer
Therese Ericsson, Antje Blank, Cornelia von Hagens, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 10, 2014
Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies
Therese Ericsson, Jesper Sundell, Angelica Torkelsson, et al.
American Journal of Nephrology
|
June 12, 2004
Safety and tolerability of high-dose angiotensin receptor blocker therapy in patients with chronic kidney disease: a pilot study
Adam J Weinberg, Dion H Zappe, Michael Ashton, et al.
Clinical and Translational Science
|
September 11, 2022
Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N-dimethyltryptamine - Implications for dose considerations
Emma Eckernäs, Christopher Timmermann, Robin Carhart-Harris, et al.
ACS Omega
|
September 28, 2020
Chiral Chromatographic Isolation on Milligram Scale of the Human African Trypanosomiasis Treatment d- and l-Eflornithine
Mikael Boberg, Anna C Jonson, Hanna Leek, et al.
Biopharmaceutics & Drug Disposition
|
March 6, 2003
Characterisation of the human liver in vitro metabolic pattern of artemisinin and auto-induction in the rat by use of nonlinear mixed effects modelling
Ulrika S H Svensson, Mika Mäki-Jouppila, Kurt-Jürgen Hoffmann, et al.
Clinical Pharmacology and Therapeutics
|
February 5, 2020
Model-Based Assessment of Variability in Isoniazid Pharmacokinetics and Metabolism in Patients Co-Infected With Tuberculosis and HIV: Implications for a Novel Dosing Strategy
Jesper Sundell, Emile Bienvenu, David Janzén, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 26, 2018
Simultaneous quantification of four first line antitubercular drugs and metabolites in human plasma by hydrophilic interaction chromatography and tandem mass spectrometry
Jesper Sundell, Emile Bienvenu, Sofia Birgersson, et al.
The AAPS Journal
|
March 26, 2022
Population Pharmacodynamic Modeling of Eflornithine-Based Treatments Against Late-Stage Gambiense Human African Trypanosomiasis and Efficacy Predictions of L-eflornithine-Based Therapy
Carl Amilon, Mikael Boberg, Joel Tarning, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 70) with videos related to
Sort By:
Page
of 7
CPT: Pharmacometrics & Systems Pharmacology
|
February 10, 2023
N,N-dimethyltryptamine affects electroencephalography response in a concentration-dependent manner-A pharmacokinetic/pharmacodynamic analysis
Emma Eckernäs, Christopher Timmermann, Robin Carhart-Harris, et al.
European Journal of Clinical Pharmacology
|
September 25, 2014
Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer
Therese Ericsson, Antje Blank, Cornelia von Hagens, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 10, 2014
Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies
Therese Ericsson, Jesper Sundell, Angelica Torkelsson, et al.
American Journal of Nephrology
|
June 12, 2004
Safety and tolerability of high-dose angiotensin receptor blocker therapy in patients with chronic kidney disease: a pilot study
Adam J Weinberg, Dion H Zappe, Michael Ashton, et al.
Clinical and Translational Science
|
September 11, 2022
Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N-dimethyltryptamine - Implications for dose considerations
Emma Eckernäs, Christopher Timmermann, Robin Carhart-Harris, et al.
ACS Omega
|
September 28, 2020
Chiral Chromatographic Isolation on Milligram Scale of the Human African Trypanosomiasis Treatment d- and l-Eflornithine
Mikael Boberg, Anna C Jonson, Hanna Leek, et al.
Biopharmaceutics & Drug Disposition
|
March 6, 2003
Characterisation of the human liver in vitro metabolic pattern of artemisinin and auto-induction in the rat by use of nonlinear mixed effects modelling
Ulrika S H Svensson, Mika Mäki-Jouppila, Kurt-Jürgen Hoffmann, et al.
Clinical Pharmacology and Therapeutics
|
February 5, 2020
Model-Based Assessment of Variability in Isoniazid Pharmacokinetics and Metabolism in Patients Co-Infected With Tuberculosis and HIV: Implications for a Novel Dosing Strategy
Jesper Sundell, Emile Bienvenu, David Janzén, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 26, 2018
Simultaneous quantification of four first line antitubercular drugs and metabolites in human plasma by hydrophilic interaction chromatography and tandem mass spectrometry
Jesper Sundell, Emile Bienvenu, Sofia Birgersson, et al.
The AAPS Journal
|
March 26, 2022
Population Pharmacodynamic Modeling of Eflornithine-Based Treatments Against Late-Stage Gambiense Human African Trypanosomiasis and Efficacy Predictions of L-eflornithine-Based Therapy
Carl Amilon, Mikael Boberg, Joel Tarning, et al.
Page
of 7